A significant reduction of tumour size was also observed in tumours derived from EV9 (0.55±0.17) and EV18 (0.18±012) ErbB2-KD cells when compared to NT controls (1±0.1, **, p = 0.017). This evidence concerns the gene ERBB2 and neoplasm.